Published in J Invest Dermatol on July 01, 1983
Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest (1984) 1.92
Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp Med (1984) 1.67
High doses of antigen-nonspecific IgG do not inhibit pemphigus acantholysis in skin organ cultures. Arch Dermatol Res (1985) 0.81
Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med (1997) 4.57
Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature (1996) 3.83
The problem of routine circumcision. Can Med Assoc J (1966) 3.17
Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med (1982) 3.09
Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid) N Engl J Med (1993) 3.06
Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol (1989) 2.77
Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis. Proc Natl Acad Sci U S A (1975) 2.75
Overexpression of transforming growth factor alpha in psoriatic epidermis. Science (1989) 2.63
Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem (1994) 2.51
The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell (2000) 2.49
Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet (1997) 2.48
Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol (1986) 2.30
DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med (1995) 2.25
Pemphigus: is there another half of the story? J Invest Dermatol (2001) 2.22
The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med (1999) 2.21
A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest (1993) 2.19
Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med (1993) 2.15
A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol (1992) 2.11
Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J Exp Med (1987) 2.09
Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet (1998) 2.09
Comparison of CD271 (adapalene) and all-trans retinoic acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression. J Invest Dermatol (1993) 2.07
Pruritus associated with nocturnal wakenings: organic or psychogenic? J Am Acad Dermatol (1989) 2.06
Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol (1992) 1.99
Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol (2000) 1.97
Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med (1998) 1.96
Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med (1999) 1.95
Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol (2007) 1.95
The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med (1989) 1.88
Paraneoplastic pemphigus presenting as a lichen planus pemphigoides-like eruption. Arch Dermatol (1993) 1.86
Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet (2000) 1.86
Complete bundle branch block as an independent predictor of all-cause mortality: report of 7,073 patients referred for nuclear exercise testing. Am J Med (2001) 1.84
The genetics of psoriasis. Arch Dermatol (1994) 1.84
Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J Infect Dis (1997) 1.75
Psoralen plus black light inhibits epidermal DNA synthesis. Arch Dermatol (1973) 1.75
GU medicine consultants' and clients' opinions on general practitioner involvement with sexual health care. Int J STD AIDS (2004) 1.71
Isolation of a Bacterial Culture That Degrades Methyl t-Butyl Ether. Appl Environ Microbiol (1994) 1.70
Molecular mechanisms of retinoid actions in skin. FASEB J (1996) 1.69
Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis. N Engl J Med (1990) 1.68
Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial. J Rheumatol (1995) 1.68
A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. J Invest Dermatol (1985) 1.67
Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest (1990) 1.67
Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med (2001) 1.65
Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study. JAMA (1988) 1.65
Contrast-enhanced cardiac magnetic resonance in a patient with familial isolated ventricular non-compaction. J Cardiovasc Magn Reson (2004) 1.65
Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation. JAMA (1992) 1.60
Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J Invest Dermatol (1985) 1.60
Reduced type I and type III procollagens in photodamaged adult human skin. J Invest Dermatol (1995) 1.60
The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research. N Engl J Med (2000) 1.58
Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma. Br J Surg (2007) 1.58
Chronic idiopathic acrocyanosis. J Am Acad Dermatol (2001) 1.57
Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J Invest Dermatol (1997) 1.56
Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment. Nat Med (1999) 1.56
Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest (1998) 1.55
Thioredoxin 2 is involved in the oxidative stress response in Escherichia coli. J Biol Chem (2000) 1.55
The role of complement in experimental bullous pemphigoid. J Clin Invest (1995) 1.55
A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest (1997) 1.53
Sulfasalazine improves psoriasis. A double-blind analysis. Arch Dermatol (1990) 1.53
Epinephrine for bronchiolitis. Cochrane Database Syst Rev (2004) 1.52
Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol (1991) 1.52
A morphometric and histologic study of the scalp in psoriasis. Paradoxical sebaceous gland atrophy and decreased hair shaft diameters without alopecia. Arch Dermatol (1989) 1.51
Cyclosporine in dermatology. J Am Acad Dermatol (1989) 1.50
c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid. J Clin Invest (2000) 1.50
Molecular mechanisms of nonablative fractionated laser resurfacing. Br J Dermatol (2010) 1.47
Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis. Arch Intern Med (1982) 1.47
Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading? Arch Dermatol (2000) 1.46
Telephone consultations in general practice: areas for improvement. J Telemed Telecare (2005) 1.45
Behçet's disease. Int J Dermatol (1984) 1.45
Bulimia nervosa and acne may be related: a case report. Can J Psychiatry (1992) 1.44
Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol (1993) 1.44
D-penicillamine-induced pemphigus foliaceus with autoantibodies to desmoglein-1 in a patient with mixed connective tissue disease. J Am Acad Dermatol (1997) 1.43
Molecular mechanisms of photoaging and its prevention by retinoic acid: ultraviolet irradiation induces MAP kinase signal transduction cascades that induce Ap-1-regulated matrix metalloproteinases that degrade human skin in vivo. J Investig Dermatol Symp Proc (1998) 1.43
The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus. J Invest Dermatol (2003) 1.43
Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro. Am J Pathol (2001) 1.42
Induction of acantholysis in organ explant culture by penicillamine and captopril. Arch Dermatol (1989) 1.42
Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest (2001) 1.42
Cyclosporine in the treatment of psoriatic arthritis. Arch Dermatol (1989) 1.41
Stratification, specialization, and proliferation of primary keratinocyte cultures. Evidence of a functioning in vitro epidermal cell system. J Cell Biol (1978) 1.40
Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy. Arch Dermatol (1995) 1.40
Hyperinsulinemia and coronary artery disease risk factors in patients with non-insulin-dependent diabetes mellitus and nondiabetics. J Am Osteopath Assoc (1996) 1.40
Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol (1994) 1.39
Heterogeneity of the bullous pemphigoid antigen: what is true and what is artifact? J Invest Dermatol (1991) 1.39
Sulfasalazine: a potential psoriasis therapy? J Am Acad Dermatol (1989) 1.39
IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta. J Immunol (1990) 1.39
Lymphocytic infiltrates of the skin in association with cyclosporine therapy. J Am Acad Dermatol (1990) 1.39
Fasting hyperglycemia in type I diabetes mellitus. J Am Osteopath Assoc (1993) 1.38
Protecting the future of sexual health services: lessons from the retail industry. Int J STD AIDS (2005) 1.38
Clinical improvement following dermabrasion of photoaged skin correlates with synthesis of collagen I. Arch Dermatol (1994) 1.36